These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7851092)

  • 1. The role of T-cell receptors in health and disease.
    Hummell DS
    Compr Ther; 1994; 20(11):616-22. PubMed ID: 7851092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skewed T-cell receptor repertoire: more than a marker of malignancy, a tool to dissect the immunopathology of inflammatory diseases.
    Pandolfi F; Cianci R; Casciano F; Pagliari D; De Pasquale T; Landolfi R; Di Sante G; Kurnick JT; Ria F
    J Biol Regul Homeost Agents; 2011; 25(2):153-61. PubMed ID: 21880203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of lck and loss of TCR-mediated signaling upon persistent engagement with complexes of peptide:MHC molecules.
    Lee JE; Cossoy MB; Chau LA; Singh B; Madrenas J
    J Immunol; 1997 Jul; 159(1):61-9. PubMed ID: 9200439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bypassing immunization: optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA.
    Nolan KF; Yun CO; Akamatsu Y; Murphy JC; Leung SO; Beecham EJ; Junghans RP
    Clin Cancer Res; 1999 Dec; 5(12):3928-41. PubMed ID: 10632322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes.
    Jyothi MD; Flavell RA; Geiger TL
    Nat Biotechnol; 2002 Dec; 20(12):1215-20. PubMed ID: 12426577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking molecular and cellular events in T-cell activation and synapse formation.
    Krogsgaard M; Huppa JB; Purbhoo MA; Davis MM
    Semin Immunol; 2003 Dec; 15(6):307-15. PubMed ID: 15001169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-T cellular interaction between CD4-CD8- regulatory T cells and T cell clones presenting TCR peptide. Its implication for TCR vaccination against experimental autoimmune encephalomyelitis.
    Kozovska MF; Yamamura T; Tabira T
    J Immunol; 1996 Aug; 157(4):1781-90. PubMed ID: 8759768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis of molecular mimicry.
    Wucherpfennig KW
    J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    Surman S; Deckhut AM; Blackman MA; Woodland DL
    J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
    Godfrey DI; Rossjohn J; McCluskey J
    Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR-independent cytokine stimulation induces non-MHC-restricted T cell activity and is negatively regulated by HLA class I.
    von Geldern M; Simm B; Braun M; Weiss EH; Schendel DJ; Falk CS
    Eur J Immunol; 2006 Sep; 36(9):2347-58. PubMed ID: 16909431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T cell survival is not directly linked to self-MHC-induced TCR signaling.
    Dorfman JR; Stefanová I; Yasutomo K; Germain RN
    Nat Immunol; 2000 Oct; 1(4):329-35. PubMed ID: 11017105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.
    Cohen CJ; Denkberg G; Lev A; Epel M; Reiter Y
    J Mol Recognit; 2003; 16(5):324-32. PubMed ID: 14523945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR reactivity in human nickel allergy indicates contacts with complementarity-determining region 3 but excludes superantigen-like recognition.
    Vollmer J; Weltzien HU; Moulon C
    J Immunol; 1999 Sep; 163(5):2723-31. PubMed ID: 10453014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiotypic T-lymphocyte receptor in animal and human autoimmune diseases].
    Kay RA; Ollier WE
    Rev Rhum Ed Fr; 1994; 61(7-8):532-45. PubMed ID: 7833889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.